APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prescription Gastrointestinal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prescription Gastrointestinal Drugs Market Analysis and Forecast 2026-2032

Report ID 174028290222 December 2025193 pages

Choose your research edition.

Industry ResearchPrescription Gastrointestinal Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Gastrointestinal Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Prescription Gastrointestinal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Gastrointestinal Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Gastrointestinal Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Gastrointestinal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prescription Gastrointestinal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prescription Gastrointestinal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prescription Gastrointestinal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prescription Gastrointestinal Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prescription Gastrointestinal Drugs include Eisai, Merck, GlaxoSmithKline, AstraZeneca, Salix Pharmaceuticals and Axcan Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prescription Gastrointestinal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prescription Gastrointestinal Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Prescription Gastrointestinal Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prescription Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prescription Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prescription Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.

Prescription Gastrointestinal Drugs Segment by Company

Eisai

Merck

GlaxoSmithKline

AstraZeneca

Salix Pharmaceuticals

Axcan Pharmaceuticals

Prescription Gastrointestinal Drugs Segment by Type

Oral

Topical

Prescription Gastrointestinal Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Prescription Gastrointestinal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Gastrointestinal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Gastrointestinal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Gastrointestinal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prescription Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prescription Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prescription Gastrointestinal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Topical Major Manufacturers Table 4. Global Prescription Gastrointestinal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Online Pharmacies Major Manufacturers Table 6. Hospital Pharmacies Major Manufacturers Table 7. Retail Pharmacies Major Manufacturers Table 8. Prescription Gastrointestinal Drugs Industry Trends Table 9. Prescription Gastrointestinal Drugs Industry Drivers Table 10. Prescription Gastrointestinal Drugs Industry Opportunities and Challenges Table 11. Prescription Gastrointestinal Drugs Industry Restraints Table 12. Global Prescription Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Prescription Gastrointestinal Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Prescription Gastrointestinal Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Prescription Gastrointestinal Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Prescription Gastrointestinal Drugs Sales by Region (2021-2026) & (k units) Table 19. Global Prescription Gastrointestinal Drugs Sales by Region (2027-2032) & (k units) Table 20. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2021-2026) Table 21. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2027-2032) Table 22. Global Prescription Gastrointestinal Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Prescription Gastrointestinal Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Prescription Gastrointestinal Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Prescription Gastrointestinal Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Prescription Gastrointestinal Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Prescription Gastrointestinal Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Prescription Gastrointestinal Drugs Manufacturers, Product Type & Application Table 30. Global Prescription Gastrointestinal Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Prescription Gastrointestinal Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Prescription Gastrointestinal Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Prescription Gastrointestinal Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 40. Global Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 41. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2026) Table 42. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2027-2032) Table 43. Global Prescription Gastrointestinal Drugs Price by Type (2021-2026) & (US$/unit) Table 44. Global Prescription Gastrointestinal Drugs Price by Type (2027-2032) & (US$/unit) Table 45. Global Prescription Gastrointestinal Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Prescription Gastrointestinal Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 53. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2026) Table 54. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2027-2032) Table 55. Global Prescription Gastrointestinal Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Prescription Gastrointestinal Drugs Price by Application (2027-2032) & (US$/unit) Table 57. Eisai Company Information Table 58. Eisai Business Overview Table 59. Eisai Prescription Gastrointestinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Eisai Prescription Gastrointestinal Drugs Product Portfolio Table 61. Eisai Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Prescription Gastrointestinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Merck Prescription Gastrointestinal Drugs Product Portfolio Table 66. Merck Recent Development Table 67. GlaxoSmithKline Company Information Table 68. GlaxoSmithKline Business Overview Table 69. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio Table 71. GlaxoSmithKline Recent Development Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Prescription Gastrointestinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio Table 76. AstraZeneca Recent Development Table 77. Salix Pharmaceuticals Company Information Table 78. Salix Pharmaceuticals Business Overview Table 79. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio Table 81. Salix Pharmaceuticals Recent Development Table 82. Axcan Pharmaceuticals Company Information Table 83. Axcan Pharmaceuticals Business Overview Table 84. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio Table 86. Axcan Pharmaceuticals Recent Development Table 87. North America Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 90. North America Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 91. North America Prescription Gastrointestinal Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 92. North America Prescription Gastrointestinal Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 93. North America Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 96. North America Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 97. North America Prescription Gastrointestinal Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 98. North America Prescription Gastrointestinal Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 99. North America Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 103. North America Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 104. North America Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 105. North America Prescription Gastrointestinal Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 106. North America Prescription Gastrointestinal Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 107. United States Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 108. Canada Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 109. Mexico Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 110. Europe Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 113. Europe Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 114. Europe Prescription Gastrointestinal Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 115. Europe Prescription Gastrointestinal Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 116. Europe Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 119. Europe Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 120. Europe Prescription Gastrointestinal Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 121. Europe Prescription Gastrointestinal Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 122. Europe Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 126. Europe Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 127. Europe Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 128. Europe Prescription Gastrointestinal Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 129. Europe Prescription Gastrointestinal Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 130. Germany Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 131. France Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 132. U.K. Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 133. Italy Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 134. Russia Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 135. Spain Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 138. Sweden Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 139. Poland Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 140. China Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 141. China Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 142. China Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 143. China Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 144. China Prescription Gastrointestinal Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 145. China Prescription Gastrointestinal Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 146. China Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 147. China Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 148. China Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 149. China Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 150. China Prescription Gastrointestinal Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 151. China Prescription Gastrointestinal Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 152. Asia Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 155. Asia Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 156. Asia Prescription Gastrointestinal Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 157. Asia Prescription Gastrointestinal Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 158. Asia Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 161. Asia Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 162. Asia Prescription Gastrointestinal Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 163. Asia Prescription Gastrointestinal Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. Asia Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 169. Asia Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 170. Asia Prescription Gastrointestinal Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 171. Asia Prescription Gastrointestinal Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 172. Japan Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 173. South Korea Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 174. India Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 175. Australia Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 181. SAMEA Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 182. SAMEA Prescription Gastrointestinal Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 183. SAMEA Prescription Gastrointestinal Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 184. SAMEA Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 187. SAMEA Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 188. SAMEA Prescription Gastrointestinal Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 189. SAMEA Prescription Gastrointestinal Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 190. SAMEA Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. SAMEA Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 195. SAMEA Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 196. SAMEA Prescription Gastrointestinal Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 197. SAMEA Prescription Gastrointestinal Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 198. Brazil Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 199. Argentina Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 200. Chile Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 201. Colombia Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 202. Peru Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 204. Israel Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 205. UAE Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 206. Turkey Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 207. Iran Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 208. Egypt Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Prescription Gastrointestinal Drugs Distributors List Table 212. Prescription Gastrointestinal Drugs Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Prescription Gastrointestinal Drugs Image Figure 2. Global Prescription Gastrointestinal Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Gastrointestinal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Topical Image Figure 6. Global Prescription Gastrointestinal Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Prescription Gastrointestinal Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Online Pharmacies Image Figure 9. Hospital Pharmacies Image Figure 10. Retail Pharmacies Image Figure 11. Global Prescription Gastrointestinal Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Prescription Gastrointestinal Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Prescription Gastrointestinal Drugs Sales (2021-2032) & (k units) Figure 17. Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Prescription Gastrointestinal Drugs Sales YoY (2021-2032) & (k units) Figure 20. Europe Prescription Gastrointestinal Drugs Sales YoY (2021-2032) & (k units) Figure 21. China Prescription Gastrointestinal Drugs Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Prescription Gastrointestinal Drugs Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales YoY (2021-2032) & (k units) Figure 24. Global Prescription Gastrointestinal Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Prescription Gastrointestinal Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Prescription Gastrointestinal Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Prescription Gastrointestinal Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Prescription Gastrointestinal Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Prescription Gastrointestinal Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Prescription Gastrointestinal Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Prescription Gastrointestinal Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Prescription Gastrointestinal Drugs Revenue Share by Type (2021-2032) Figure 40. North America Prescription Gastrointestinal Drugs Sales Share by Type (2021-2032) Figure 41. North America Prescription Gastrointestinal Drugs Revenue Share by Application (2021-2032) Figure 42. North America Prescription Gastrointestinal Drugs Sales Share by Application (2021-2032) Figure 43. North America Prescription Gastrointestinal Drugs Revenue Share by Country (2021-2032) Figure 44. North America Prescription Gastrointestinal Drugs Sales Share by Country (2021-2032) Figure 45. Europe Prescription Gastrointestinal Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Prescription Gastrointestinal Drugs Sales Share by Type (2021-2032) Figure 47. Europe Prescription Gastrointestinal Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Prescription Gastrointestinal Drugs Sales Share by Application (2021-2032) Figure 49. Europe Prescription Gastrointestinal Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Prescription Gastrointestinal Drugs Sales Share by Country (2021-2032) Figure 51. China Prescription Gastrointestinal Drugs Revenue Share by Type (2021-2032) Figure 52. China Prescription Gastrointestinal Drugs Sales Share by Type (2021-2032) Figure 53. China Prescription Gastrointestinal Drugs Revenue Share by Application (2021-2032) Figure 54. China Prescription Gastrointestinal Drugs Sales Share by Application (2021-2032) Figure 55. Asia Prescription Gastrointestinal Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Prescription Gastrointestinal Drugs Sales Share by Type (2021-2032) Figure 57. Asia Prescription Gastrointestinal Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Prescription Gastrointestinal Drugs Sales Share by Application (2021-2032) Figure 59. Asia Prescription Gastrointestinal Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Prescription Gastrointestinal Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Prescription Gastrointestinal Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Prescription Gastrointestinal Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Prescription Gastrointestinal Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Prescription Gastrointestinal Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Prescription Gastrointestinal Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Prescription Gastrointestinal Drugs Sales Share by Country (2021-2032) Figure 67. Prescription Gastrointestinal Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prescription Gastrointestinal Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Topical
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Eisai
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • Salix Pharmaceuticals
  • Axcan Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prescription Gastrointestinal Drugs Market by Type
  3. 1.2.1 Global Prescription Gastrointestinal Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Topical
  6. 1.3 Prescription Gastrointestinal Drugs Market by Application
  7. 1.3.1 Global Prescription Gastrointestinal Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Online Pharmacies
  9. 1.3.3 Hospital Pharmacies
  10. 1.3.4 Retail Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Prescription Gastrointestinal Drugs Market Dynamics
  1. 2.1 Prescription Gastrointestinal Drugs Industry Trends
  2. 2.2 Prescription Gastrointestinal Drugs Industry Drivers
  3. 2.3 Prescription Gastrointestinal Drugs Industry Opportunities and Challenges
  4. 2.4 Prescription Gastrointestinal Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prescription Gastrointestinal Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prescription Gastrointestinal Drugs Revenue by Region
  3. 3.2.1 Global Prescription Gastrointestinal Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prescription Gastrointestinal Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Prescription Gastrointestinal Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prescription Gastrointestinal Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prescription Gastrointestinal Drugs Sales by Region
  9. 3.4.1 Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prescription Gastrointestinal Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Prescription Gastrointestinal Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prescription Gastrointestinal Drugs Revenue by Manufacturers
  2. 4.1.1 Global Prescription Gastrointestinal Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prescription Gastrointestinal Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prescription Gastrointestinal Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prescription Gastrointestinal Drugs Sales by Manufacturers
  6. 4.2.1 Global Prescription Gastrointestinal Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prescription Gastrointestinal Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prescription Gastrointestinal Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prescription Gastrointestinal Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prescription Gastrointestinal Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prescription Gastrointestinal Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Prescription Gastrointestinal Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prescription Gastrointestinal Drugs Market CR5 and HHI
  16. 4.8.2 2025 Prescription Gastrointestinal Drugs Tier 1, Tier 2, and Tier 3
5 Prescription Gastrointestinal Drugs Market by Type
  1. 5.1 Global Prescription Gastrointestinal Drugs Revenue by Type
  2. 5.1.1 Global Prescription Gastrointestinal Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prescription Gastrointestinal Drugs Sales by Type
  6. 5.2.1 Global Prescription Gastrointestinal Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prescription Gastrointestinal Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prescription Gastrointestinal Drugs Price by Type
6 Prescription Gastrointestinal Drugs Market by Application
  1. 6.1 Global Prescription Gastrointestinal Drugs Revenue by Application
  2. 6.1.1 Global Prescription Gastrointestinal Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prescription Gastrointestinal Drugs Sales by Application
  6. 6.2.1 Global Prescription Gastrointestinal Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prescription Gastrointestinal Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prescription Gastrointestinal Drugs Price by Application
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Prescription Gastrointestinal Drugs Product Portfolio
  6. 7.1.5 Eisai Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Prescription Gastrointestinal Drugs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 GlaxoSmithKline
  14. 7.3.1 GlaxoSmithKline Company Information
  15. 7.3.2 GlaxoSmithKline Business Overview
  16. 7.3.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
  18. 7.3.5 GlaxoSmithKline Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 Salix Pharmaceuticals
  26. 7.5.1 Salix Pharmaceuticals Company Information
  27. 7.5.2 Salix Pharmaceuticals Business Overview
  28. 7.5.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
  30. 7.5.5 Salix Pharmaceuticals Recent Developments
  31. 7.6 Axcan Pharmaceuticals
  32. 7.6.1 Axcan Pharmaceuticals Company Information
  33. 7.6.2 Axcan Pharmaceuticals Business Overview
  34. 7.6.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
  36. 7.6.5 Axcan Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Prescription Gastrointestinal Drugs Market Size by Type
  2. 8.1.1 North America Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Prescription Gastrointestinal Drugs Price by Type (2021-2032)
  5. 8.2 North America Prescription Gastrointestinal Drugs Market Size by Application
  6. 8.2.1 North America Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Prescription Gastrointestinal Drugs Price by Application (2021-2032)
  9. 8.3 North America Prescription Gastrointestinal Drugs Market Size by Country
  10. 8.3.1 North America Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prescription Gastrointestinal Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Prescription Gastrointestinal Drugs Market Size by Type
  2. 9.1.1 Europe Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Prescription Gastrointestinal Drugs Price by Type (2021-2032)
  5. 9.2 Europe Prescription Gastrointestinal Drugs Market Size by Application
  6. 9.2.1 Europe Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Prescription Gastrointestinal Drugs Price by Application (2021-2032)
  9. 9.3 Europe Prescription Gastrointestinal Drugs Market Size by Country
  10. 9.3.1 Europe Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prescription Gastrointestinal Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Prescription Gastrointestinal Drugs Market Size by Type
  2. 10.1.1 China Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Prescription Gastrointestinal Drugs Price by Type (2021-2032)
  5. 10.2 China Prescription Gastrointestinal Drugs Market Size by Application
  6. 10.2.1 China Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Prescription Gastrointestinal Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prescription Gastrointestinal Drugs Market Size by Type
  2. 11.1.1 Asia Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Prescription Gastrointestinal Drugs Price by Type (2021-2032)
  5. 11.2 Asia Prescription Gastrointestinal Drugs Market Size by Application
  6. 11.2.1 Asia Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Prescription Gastrointestinal Drugs Price by Application (2021-2032)
  9. 11.3 Asia Prescription Gastrointestinal Drugs Market Size by Country
  10. 11.3.1 Asia Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prescription Gastrointestinal Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prescription Gastrointestinal Drugs Market Size by Type
  2. 12.1.1 SAMEA Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prescription Gastrointestinal Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Prescription Gastrointestinal Drugs Market Size by Application
  6. 12.2.1 SAMEA Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prescription Gastrointestinal Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Prescription Gastrointestinal Drugs Market Size by Country
  10. 12.3.1 SAMEA Prescription Gastrointestinal Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prescription Gastrointestinal Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prescription Gastrointestinal Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prescription Gastrointestinal Drugs Value Chain Analysis
  2. 13.1.1 Prescription Gastrointestinal Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prescription Gastrointestinal Drugs Production Mode & Process
  6. 13.2 Prescription Gastrointestinal Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prescription Gastrointestinal Drugs Distributors
  9. 13.2.3 Prescription Gastrointestinal Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst